We’re proud to share that Martin Holm-Petersen, Qinecsa’s Chief Strategy Officer, is featured in Clinical Research News’s “Trendspotting: Predictions for Clinical Research in 2025”.
As part of this experts roundup, Martin shares his vision on how unified adverse event platforms and AI are transforming pharmacovigilance—making clinical trials more efficient and patient-centric.
Qinecsa Solutions combines best-in-class technology and scientific expertise to connect life science companies with the right safety solutions. Find out more at https://qinecsa.com/.
